Sign in to continue:

Monday, March 2nd, 2026

CBRE Group, Inc. 8-K Filing February 2026 – Company Information, Address, Trading Symbol & Entity Details

CBRE Group, Inc. Files 8-K: Executive Compensation Update for 2026

Key Points:

  • CBRE Group, Inc. (NYSE: CBRE) filed a Form 8-K on February 27, 2026, disclosing key changes in executive compensation for the Chief Legal & Administrative Officer and Corporate Secretary, Chad J. Doellinger.
  • This filing provides details on the long-term equity incentive and compensation arrangements for the executive, which are often closely watched by investors for signals about the company’s talent retention, alignment of interests with shareholders, and broader management strategy.

Detailed Compensation Breakdown:

Executive Base Salary Annual Performance Award Target Core EPS Award Target Relative TSR Award Target Total Equity Award Target
Chad J. Doellinger
Chief Legal & Administrative Officer and Corporate Secretary
\$700,000 \$1,150,000 \$1,300,000 \$1,500,000 \$3,000,000

What Investors Should Know:

  • Executive Retention and Incentivization: The substantial long-term equity incentives and performance-based awards indicate CBRE’s commitment to retaining top talent and aligning executive interests with those of shareholders through performance metrics such as Core EPS (Earnings Per Share) and Relative TSR (Total Shareholder Return).
  • Potential for Price Sensitivity: Compensation changes for named executive officers, especially with sizeable equity awards, can have implications for share dilution, future earnings, and management stability—factors that may influence investor sentiment and share price.
  • No Indication of Management Change: There is no announcement of resignation, departure, or new appointments, suggesting continuity in senior management at this time.

Additional Information:

  • The filing confirms that CBRE Group, Inc. is not an emerging growth company under the SEC definition.
  • No written communications, soliciting materials, or tender offers are associated with this filing.
  • The company’s Class A Common Stock (\$0.01 par value per share) continues to trade on the New York Stock Exchange under the symbol “CBRE”.

Shareholder Impact:

  • While compensation updates do not immediately affect operational results, they may influence perceptions of governance and long-term value creation. Investors should monitor future filings for any changes in executive team structure or further updates to compensation plans.

Disclaimer: This article is for informational purposes only. It is not a solicitation to buy or sell securities. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions. The information herein is derived from CBRE Group, Inc.’s official SEC filing as of February 27, 2026, and is subject to change without notice.

View CBRE GROUP, INC. Historical chart here



Lunai Bioworks Inc. Receives Nasdaq Delisting Notice – 8-K Filing Details, Company History, and Key Information

LUNAI BIOWORKS, INC. – Nasdaq Delisting Notice and Investor Implications Lunai Bioworks, Inc. Receives Nasdaq Delisting Notice: What Investors Need to Know Key Points from the SEC 8-K Filing Delisting Notice: On February 6,...

Westamerica Bancorporation 2025 Annual Report: Financials, Business Overview, and Regulatory Disclosures (Form 10-K)

Westamerica Bancorporation 2025 Annual Report: Detailed Investor Analysis Westamerica Bancorporation 2025 Annual Report: Key Highlights and Investor Insights Overview Westamerica Bancorporation, a leading bank holding company serving Northern and Central California, has released its...

Innovative Industrial Properties (IIPR) Reports Q4 & Full Year 2025 Financial Results: Revenue, AFFO, Dividends, and Portfolio Updates

Innovative Industrial Properties Reports Q4 and Full-Year 2025 Results: Strategic Portfolio Moves, Tenant Resolutions, and Robust Capital Activity Key Financial Highlights Total Revenues: \$266.0 million for FY2025 (Q4: \$66.7 million), down from \$308.5 million...

   Ad